J&J to pay $2.2B in drug marketing penalties – USA TODAY

J&J to pay $ 2.2B in drug marketing penalties
Johnson & Johnson has agreed to pay more than $ 2.2 billion to settle criminal and civil claims that it marketed the antipsychotic drug Risperdal and other medications for off-label uses and paid kickbacks to a large pharmacy, the Justice Department said 
Johnson & Johnson agrees to pay $ 2.2 billion in drug-marketing settlementWashington Post
Johnson & Johnson, Accused of Kickbacks, Fined Record-Setting $ 2.2 BillionBoise Weekly
Janssen, J&J Pay Millions to Settle Risperdal Off-Label Promotion AllegationsHarrisMartin Publishing
Nebraska Radio Network –Bloomberg –New York Times
all 268 news articles »

Business – Google News

Short URL: http://globalnewsmagazine.com/?p=3141

Posted by on Nov 5 2013. Filed under BUSINESS. You can follow any responses to this entry through the RSS 2.0. Responses are currently closed, but you can trackback from your own site.

Comments are closed

Photo Gallery

Log in | Designed by Buy Websites

Disclaimer : All content including images in this site is copyright to their rightful owners. No copyright infringement is intended.